{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:08:59Z","timestamp":1790251739270,"version":"4.1.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T00:00:00Z","timestamp":1526601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R21NS083006"],"award-info":[{"award-number":["R21NS083006"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS089022"],"award-info":[{"award-number":["R01NS089022"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P50AG047266"],"award-info":[{"award-number":["P50AG047266"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG046139"],"award-info":[{"award-number":["U01AG046139"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SantaFe HealthCare Alzheimer's Disease Research Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13024-018-0253-9","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T04:23:01Z","timestamp":1526617381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differential induction of mutant SOD1 misfolding and aggregation by tau and \u03b1-synuclein pathology"],"prefix":"10.1186","volume":"13","author":[{"given":"Michael C.","family":"Pace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Fromholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit I.","family":"Giasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jada","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Borchelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"253_CR1","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0140-6736(97)02073-4","volume":"350","author":"RW Carrell","year":"1997","unstructured":"Carrell RW, Lomas DA. Conformational disease. Lancet. 1997;350:134\u20138.","journal-title":"Lancet"},{"key":"253_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0968-0004(99)01445-0","volume":"24","author":"CM Dobson","year":"1999","unstructured":"Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci. 1999;24:329\u201332.","journal-title":"Trends Biochem Sci"},{"key":"253_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat Rev Neurosci. 2003;4:49\u201360. Available from: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12511861 .","journal-title":"Nat Rev Neurosci"},{"key":"253_CR4","doi-asserted-by":"crossref","unstructured":"Spillantini MG, Goedert M, Crowther RA, Murrell JR, Farlow MR, Ghetti B. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments. Proc Natl Acad Sci U S A. [Internet]. 1997;94:4113\u20138. Available from: http:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=20577&tool=pmcentrez&rendertype=abstract .","DOI":"10.1073\/pnas.94.8.4113"},{"key":"253_CR5","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/nm1067","volume":"10","author":"E Bossy-Wetzel","year":"2004","unstructured":"Bossy-Wetzel E, Schwarzenbacher R, Lipton SA. Molecular pathways to neurodegeneration. Nat Med. 2004;10 Suppl:S2\u20139.","journal-title":"Nat Med"},{"key":"253_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1046\/j.1471-4159.2000.0750436.x","volume":"75","author":"JN Keller","year":"2000","unstructured":"Keller JN, Hanni KB, Markesbery WR. Impaired proteasome function in Alzheimer\u2019s disease. J Neurochem. 2000;75:436\u20139.","journal-title":"J Neurochem"},{"key":"253_CR7","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1089\/ars.2013.5802","volume":"21","author":"C McKinnon","year":"2014","unstructured":"McKinnon C, Tabrizi SJ. The ubiquitin-proteasome system in neurodegeneration. Antioxid Redox Signal. 2014;21:2302\u201321. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24437518 .","journal-title":"Antioxid Redox Signal"},{"key":"253_CR8","doi-asserted-by":"crossref","unstructured":"Wong E, Cuervo AM. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci. 2010 [cited 2016 May 2];13:805\u2013811. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20581817 .","DOI":"10.1038\/nn.2575"},{"key":"253_CR9","doi-asserted-by":"crossref","unstructured":"Myeku N, Clelland CL, Emrani S, Kukushkin NV, Yu WH, Goldberg AL, et al. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling. Nat Med. 2015;6:1\u201311. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4787271\/ .","DOI":"10.1038\/nm.4011"},{"key":"253_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.neurobiolaging.2008.07.008","volume":"31","author":"E Emmanouilidou","year":"2010","unstructured":"Emmanouilidou E, Stefanis L, Vekrellis K. Cell-produced \u03b1-synuclein oligomers are targeted to, and impair, the 26S proteasome. Neurobiol Aging. 2010;31:953\u201368. Elsevier Inc., Available from: https:\/\/doi.org\/10.1016\/j.neurobiolaging.2008.07.008 .","journal-title":"Neurobiol Aging"},{"key":"253_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12640-009-9094-1","volume":"17","author":"M Dyllick-Brenzinger","year":"2010","unstructured":"Dyllick-Brenzinger M, D\u2019Souza CA, Dahlmann B, Kloetzel P-M, Tandon A. Reciprocal effects of \u03b1-Synuclein overexpression and proteasome inhibition in neuronal cells and tissue. Neurotox Res. 2010;17:215\u201327. Available from: http:\/\/link.springer.com\/10.1007\/s12640-009-9094-1 .","journal-title":"Neurotox Res"},{"key":"253_CR12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/acel.12359","volume":"14","author":"JM Deger","year":"2015","unstructured":"Deger JM, Gerson JE, Kayed R. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration. Aging Cell. 2015;14:715\u201324.","journal-title":"Aging Cell"},{"key":"253_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1046\/j.1471-4159.2003.01642.x","volume":"85","author":"S Keck","year":"2003","unstructured":"Keck S, Nitsch R, Grune T, Ullrich O. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer\u2019s disease. J Neurochem. 2003;85:115\u201322.","journal-title":"J Neurochem"},{"key":"253_CR14","doi-asserted-by":"crossref","unstructured":"Han DH, Na H-K, Choi WH, Lee JH, Kim YK, Won C, et al. Direct cellular delivery of human proteasomes to delay tau aggregation. Nat Commun. 2014;5:5633. Nature Publishing Group; Available from: http:\/\/www.nature.com\/articles\/ncomms6633 .","DOI":"10.1038\/ncomms6633"},{"key":"253_CR15","doi-asserted-by":"crossref","unstructured":"Tai HC, Serrano-Pozo A, Hashimoto T, Frosch MP, Spires-Jones TL, Hyman BT. The synaptic accumulation of hyperphosphorylated tau oligomers in alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol. 2012 [cited 2017 Mar 10];181:1426\u20131435. Available from: https:\/\/ajp.amjpathol.org\/article\/S0002-9440(12)00514-7\/fulltext .","DOI":"10.1016\/j.ajpath.2012.06.033"},{"key":"253_CR16","unstructured":"Metcalfe MJ, Huang Q, Figueiredo-Pereira ME. Coordination between proteasome impairment and caspase activation leading to TAU pathology: neuroprotection by cAMP. Cell Death Dis. 2012;3:e326. Nature Publishing Group, Available from: http:\/\/www.nature.com\/articles\/cddis201270 ."},{"key":"253_CR17","doi-asserted-by":"crossref","unstructured":"Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci. 1998:516\u201320.","DOI":"10.1016\/S0166-2236(98)01276-4"},{"key":"253_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (80-. ). 2006;314:130\u20133. Available from: http:\/\/www.sciencemag.org\/cgi\/doi\/10.1126\/science.1134108 .","journal-title":"Science (80-. )"},{"key":"253_CR19","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1074\/jbc.M305838200","volume":"279","author":"H Shimura","year":"2004","unstructured":"Shimura H, Schwartz D, Gygi SP, Kosik KS. CHIP-Hsc70 complex Ubiquitinates phosphorylated tau and enhances cell survival. J Biol Chem. 2004;279:4869\u201376.","journal-title":"J Biol Chem"},{"key":"253_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0896-6273(01)00177-5","volume":"29","author":"MY Sherman","year":"2001","unstructured":"Sherman MY, Goldberg AL. Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases. Neuron. 2001;29:15\u201332.","journal-title":"Neuron"},{"key":"253_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp MS, Park SH, Hartl UU. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends cell biol. 2014;24:506\u201314. Elsevier Ltd,Available from: https:\/\/doi.org\/10.1016\/j.tcb.2014.05.003 .","journal-title":"Trends cell biol"},{"key":"253_CR22","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.1141448","volume":"319","author":"WE Balch","year":"2008","unstructured":"Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting Proteostasis for disease intervention. Science (80-. ). 2008;319:916\u20139.","journal-title":"Science (80-. )"},{"key":"253_CR23","doi-asserted-by":"crossref","unstructured":"Powers ET, Balch WE. Diversity in the origins of proteostasis networks-a driver for protein function in evolution. Nat Rev Mol Cell Biol. 2013 [cited 2018 Jan 2]. p. 237\u2013248. Available from: https:\/\/www.nature.com\/articles\/nrm3542.pdf .","DOI":"10.1038\/nrm3542"},{"key":"253_CR24","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nsmb993","volume":"12","author":"M Haslbeck","year":"2005","unstructured":"Haslbeck M, Franzmann T, Weinfurtner D, Buchner J. Some like it hot: the structure and function of small heat-shock proteins. Nat Struct Mol Biol. 2005;12:842\u20136.","journal-title":"Nat Struct Mol Biol"},{"key":"253_CR25","doi-asserted-by":"crossref","unstructured":"Dantuma NP, Bott LC. The ubiquitin-proteasome system in neurodegenerative diseases: precipitating factor, yet part of the solution. Front Mol Neurosci. 2014;7:70. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2014.00070\/full","DOI":"10.3389\/fnmol.2014.00070"},{"key":"253_CR26","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/ncb0805-742","volume":"7","author":"S Elsasser","year":"2005","unstructured":"Elsasser S, Finley D. Delivery of ubiquitinated substrates to protein-unfolding machines. Nat Cell Biol. 2005;7:742\u20139.","journal-title":"Nat Cell Biol"},{"key":"253_CR27","doi-asserted-by":"crossref","unstructured":"Kundu M, Thompson CB. Autophagy: basic principles and relevance to disease. Annu Rev Pathol. 2008 [cited 2016 May 2];3:427\u2013455. Available from: https:\/\/www.annualreviews.org\/doi\/10.1146\/annurev.pathmechdis.2.010506.091842 .","DOI":"10.1146\/annurev.pathmechdis.2.010506.091842"},{"key":"253_CR28","doi-asserted-by":"crossref","unstructured":"Gidalevitz T, Ben-Zvi A, Ho KH, Brignull HR, Morimoto RI. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science (80-. ). 2006 [cited 2016 May 4];311:1471\u20131474. Available from: http:\/\/science.sciencemag.org\/content\/311\/5766\/1471 .","DOI":"10.1126\/science.1124514"},{"key":"253_CR29","doi-asserted-by":"crossref","unstructured":"Gidalevitz T, Krupinski T, Garcia S, Morimoto RI. Destabilizing protein polymorphisms in the genetic background direct phenotypic expression of mutant SOD1 toxicity. PLoS Genet. 2009;5","DOI":"10.1371\/journal.pgen.1000399"},{"key":"253_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1097\/NEN.0000000000000018","volume":"72","author":"M Colom-Cadena","year":"2013","unstructured":"Colom-Cadena M, Gelpi E, Charif S, Belbin O, Blesa R, Marti MJ, et al. Confluence of alpha-synuclein, tau, and beta-amyloid pathologies in dementia with Lewy bodies. J Neuropathol Exp Neurol. 2013;72:1203\u201312.","journal-title":"J Neuropathol Exp Neurol"},{"key":"253_CR31","doi-asserted-by":"crossref","unstructured":"Higashi S, Iseki E, Yamamoto R, Minegishi M, Hino H, Fujisawa K, et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer\u2019s disease and dementia with Lewy bodies. Brain Res. 2007 [cited 2016 Jun 16];1184:284\u2013294. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S000689930702224X .","DOI":"10.1016\/j.brainres.2007.09.048"},{"key":"253_CR32","doi-asserted-by":"crossref","unstructured":"Spires-Jones TL, Attems J, Thal DR. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. Springer Berlin Heidelberg. 2017:1\u201319.","DOI":"10.1007\/s00401-017-1709-7"},{"key":"253_CR33","doi-asserted-by":"crossref","unstructured":"Walker L, Kirsty Mcaleese E, Thomas AJ, Johnson M, Martin-ruiz C, et al. Neuropathologically mixed Alzheimer\u2019s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes. Acta Neuropathol. 2015 [cited 2017 Jun 27];129:729\u2013748. Available from: https:\/\/link.springer.com\/content\/pdf\/10.1007%2Fs00401-015-1406-3.pdf .","DOI":"10.1007\/s00401-015-1406-3"},{"key":"253_CR34","doi-asserted-by":"crossref","unstructured":"James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA. TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia. Brain. 2016 [cited 2017 Jun 27];139:2983\u20132993. Available from: https:\/\/academic.oup.com\/brain\/article\/139\/11\/2983\/2422129 .","DOI":"10.1093\/brain\/aww224"},{"key":"253_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00401-013-1123-8","volume":"126","author":"AK Clippinger","year":"2013","unstructured":"Clippinger AK, D\u2019Alton S, Lin WL, Gendron TF, Howard J, Borchelt DR, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathol. 2013;126:39\u201350.","journal-title":"Acta Neuropathol"},{"key":"253_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-015-0062-3","volume":"10","author":"AM Helferich","year":"2015","unstructured":"Helferich AM, Ruf WP, Grozdanov V, Freischmidt A, Feiler MS, Zondler L, et al. \u03b1-synuclein interacts with SOD1 and promotes its oligomerization. Mol Neurodegener. 2015;10:66. Available from: http:\/\/www.molecularneurodegeneration.com\/content\/10\/1\/66 .","journal-title":"Mol Neurodegener"},{"key":"253_CR37","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1126\/science.1082324","volume":"300","author":"BI Giasson","year":"2003","unstructured":"Giasson BI, Forman MS, Higuchi M, Golbe LI, Graves CL, Kotzbauer PT, et al. Initiation and synergistic fibrillization of tau and alpha-Synuclein. Science (80-. ). 2003;300:636\u201340. Available from: http:\/\/www.sciencemag.org\/cgi\/doi\/10.1126\/science.1082324 .","journal-title":"Science (80-. )"},{"key":"253_CR38","doi-asserted-by":"publisher","unstructured":"Guo JL, Covell DJ, Daniels JP, Iba M, Stieber A, Zhang B, et al. Distinct \u03b1-Synuclein Strains Differentially Promote Tau Inclusions in Neurons. 2013 [cited 2017 Jun 27]; Available from: https:\/\/doi.org\/10.1016\/j.cell.2013.05.057 .","DOI":"10.1016\/j.cell.2013.05.057"},{"key":"253_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.ppat.1003537","volume":"9","author":"R Morales","year":"2013","unstructured":"Morales R, Moreno-Gonzalez I, Soto C. Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein Misfolding diseases. PLoS Pathog. 2013;9:1\u20134.","journal-title":"PLoS Pathog"},{"key":"253_CR40","doi-asserted-by":"crossref","unstructured":"Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL, Krishnamurthy S, Paulucci-Holthauzen AA, Sengupta U, Lasagna-Reeves CA, et al. Amyloid-\u03b2 oligomers as a template for secondary amyloidosis in Alzheimer\u2019s disease. 2014 [cited 2017 Jun 27]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0969996114002393?via%3Dihub .","DOI":"10.1016\/j.nbd.2014.08.008"},{"key":"253_CR41","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00401-015-1525-x","volume":"131","author":"B Vasconcelos","year":"2016","unstructured":"Vasconcelos B, Stancu IC, Buist A, Bird M, Wang P, Vanoosthuyse A, et al. Heterotypic seeding of tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of tau-pathology in vivo. Acta Neuropathol. Springer Berlin Heidelberg. 2016;131:549\u201369.","journal-title":"Acta Neuropathol"},{"key":"253_CR42","doi-asserted-by":"crossref","unstructured":"Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R, et al. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology. Proc Natl Acad Sci U S A. 1999 [cited 2016 May 6];96:4604\u20134609. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC16379\/ .","DOI":"10.1073\/pnas.96.8.4604"},{"key":"253_CR43","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00401-014-1342-7","volume":"128","author":"JI Ayers","year":"2014","unstructured":"Ayers JI, Fromholt S, Koch M, DeBosier A, McMahon B, Xu G, et al. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791\u2013803.","journal-title":"Acta Neuropathol"},{"key":"253_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-015-1514-0","volume":"131","author":"JI Ayers","year":"2016","unstructured":"Ayers JI, Fromholt SE, O\u2019Neal VM, Diamond JH, Borchelt DR. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103\u201314.","journal-title":"Acta Neuropathol"},{"key":"253_CR45","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00401-016-1623-4","volume":"132","author":"JI Ayers","year":"2016","unstructured":"Ayers JI, Diamond J, Sari A, Fromholt S, Galaleldeen A, Ostrow LW, et al. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol. Springer Berlin Heidelberg. 2016;132:827\u201340.","journal-title":"Acta Neuropathol"},{"key":"253_CR46","doi-asserted-by":"crossref","unstructured":"Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, Furtak K, et al. Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci U S A. 2009 [cited 2016 May 2];106:1392\u20131397. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2631083\/ .","DOI":"10.1073\/pnas.0813045106"},{"key":"253_CR47","doi-asserted-by":"crossref","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet. 2000 [cited 2016 May 2];25:402\u2013405. Available from: http:\/\/www.nature.com\/articles\/ng0800_402 .","DOI":"10.1038\/78078"},{"key":"253_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","volume":"34","author":"BI Giasson","year":"2002","unstructured":"Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VMY. Neuronal \u03b1-synucleinopathy with severe movement disorder in mice expressing A53T human \u03b1-synuclein. Neuron. 2002;34:521\u201333.","journal-title":"Neuron"},{"key":"253_CR49","doi-asserted-by":"crossref","unstructured":"Ramsden M, Kotilinek L, Forster C, Paulson J, McGowan E, SantaCruz K, et al. Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L). J Neurosci. 2005 [cited 2016 May 2];25:10637\u201310647. Available from: http:\/\/www.jneurosci.org\/content\/25\/46\/10637 .","DOI":"10.1523\/JNEUROSCI.3279-05.2005"},{"key":"253_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K SantaCruz","year":"2005","unstructured":"SantaCruz K, Lewis J, Spires-Jones TL, Paulson J, Kotilinek L, Ingelsson M, et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science (80- ). 2005;309:476\u201381. Available from: http:\/\/www.sciencemag.org\/cgi\/doi\/10.1126\/science.1113694 .","journal-title":"Science (80- )"},{"key":"253_CR51","doi-asserted-by":"crossref","unstructured":"Sacino AN, Brooks M, Thomas MA, McKinney AB, Lee S, Regenhardt RW, et al. Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice. Proc Natl Acad Sci U S A. 2014 [cited 2016 May 27];111:1\u20136. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4115570\/ .","DOI":"10.1073\/pnas.1321785111"},{"key":"253_CR52","doi-asserted-by":"crossref","unstructured":"Wang J, Slunt H, Gonzales V, Fromholt D, Coonfield M, Copeland NG, et al. Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature. Hum Mol Genet. 2003 [cited 2016 May 2];12:2753\u20132764. Available from: https:\/\/academic.oup.com\/hmg\/article\/12\/21\/2753\/558413 .","DOI":"10.1093\/hmg\/ddg312"},{"key":"253_CR53","doi-asserted-by":"crossref","unstructured":"Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR. Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci U S A. 2009;106:7774\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2675570\/ .","DOI":"10.1073\/pnas.0902505106"},{"key":"253_CR54","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1093\/hmg\/ddt121","volume":"22","author":"G Xu","year":"2013","unstructured":"Xu G, Stevens SM, Moore BD, McClung S, Borchelt DR. Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of alzheimer-type amyloidosis. Hum Mol Genet. 2013;22:2765\u201374.","journal-title":"Hum Mol Genet"},{"key":"253_CR55","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","volume":"18","author":"LI Bruijn","year":"1997","unstructured":"Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327\u201338.","journal-title":"Neuron"},{"key":"253_CR56","doi-asserted-by":"crossref","unstructured":"Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001 [cited 2016 Jun 8];293:1487\u20131491. Available from: http:\/\/science.sciencemag.org\/content\/293\/5534\/1487 .","DOI":"10.1126\/science.1058189"},{"key":"253_CR57","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun. 2006;351:602\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"253_CR58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","volume":"86","author":"A Israelson","year":"2015","unstructured":"Israelson A, Ditsworth D, Sun S, Song SW, Liang J, Hruska-Plochan M, et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 2015;86:218\u201332. Elsevier Inc,Available from: https:\/\/doi.org\/10.1016\/j.neuron.2015.02.034","journal-title":"Neuron"},{"key":"253_CR59","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.1523\/JNEUROSCI.23-13-05789.2003","volume":"23","author":"Z Batulan","year":"2003","unstructured":"Batulan Z, Shinder GA, Minotti S, He BP, Doroudchi MM, Nalbantoglu J, et al. High threshold for induction of the stress response in motor neurons is associated with failure to activate HSF1. J Neurosci. 2003;23:5789\u201398.","journal-title":"J Neurosci"},{"key":"253_CR60","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nm1021","volume":"10","author":"D Kieran","year":"2004","unstructured":"Kieran D, Kalmar B, Dick JRT, Riddoch-Contreras J, Burnstock G, Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays disease progression in ALS mice. Nat Med. 2004;10:402\u20135.","journal-title":"Nat Med"},{"key":"253_CR61","doi-asserted-by":"crossref","unstructured":"Koch Y, Helferich AM, Steinacker P, Oeckl P, Walther P, Weishaupt JH, et al. Aggregated \u03b1-Synuclein increases SOD1 oligomerization in a mouse model of amyotrophic lateral sclerosis. Am J Pathol. 2016 [cited 2017 Jun 27];186:2152\u20132161. Available from: http:\/\/ajp.amjpathol.org\/article\/S0002-9440(16)30120-1\/pdf .","DOI":"10.1016\/j.ajpath.2016.04.008"},{"key":"253_CR62","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.brainres.2016.04.010","volume":"1648","author":"S Parakh","year":"2016","unstructured":"Parakh S, Atkin JD. Protein folding alterations in amyotrophic lateral sclerosis. Brain res. 2016;1648:633\u201349. Elsevier, Available from: https:\/\/doi.org\/10.1016\/j.brainres.2016.04.010 .","journal-title":"Brain res."},{"key":"253_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.1604885113","volume":"113","author":"M Nagy","year":"2016","unstructured":"Nagy M, Fenton WA, Li D, Furtak K, Horwich AL. Extended survival of misfolded G85R SOD1-linked ALS mice by transgenic expression of chaperone Hsp110. Proc Natl Acad Sci. 2016;113:1\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"253_CR64","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1002\/jnr.21721","volume":"86","author":"M Sarkar","year":"2008","unstructured":"Sarkar M, Kuret J, Lee G. Two motifs within the tau microtubule-binding domain mediate its association with the hsc70 molecular chaperone. J Neurosci Res. 2008;86:2763\u201373.","journal-title":"J Neurosci Res"},{"key":"253_CR65","doi-asserted-by":"publisher","first-page":"16798","DOI":"10.1074\/jbc.M110.113753","volume":"285","author":"UK Jinwal","year":"2010","unstructured":"Jinwal UK, O\u2019Leary JC, Borysov SI, Jones JR, Li Q, Koren J, et al. Hsc70 rapidly engages tau after microtubule destabilization. J Biol Chem. 2010;285:16798\u2013805.","journal-title":"J Biol Chem"},{"key":"253_CR66","doi-asserted-by":"crossref","unstructured":"Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, et al. Chaperones increase association of tau protein with microtubules. Proc Natl Acad Sci U S A. 2003 [cited 2016 Jul 2];100:721\u2013726. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC141063\/ .","DOI":"10.1073\/pnas.242720499"},{"key":"253_CR67","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1093\/hmg\/ddh083","volume":"13","author":"L Petrucelli","year":"2004","unstructured":"Petrucelli L, Dickson D, Kehoe K, Taylor J, Snyder H, Grover A, et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum Mol Genet. 2004;13:703\u201314.","journal-title":"Hum Mol Genet"},{"key":"253_CR68","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1172\/JCI29715","volume":"117","author":"CA Dickey","year":"2007","unstructured":"Dickey CA, Kamal A, Lundgren K, Klosak N, Bailey RM, Dunmore J, et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J Clin Invest. 2007;117:648\u201358.","journal-title":"J Clin Invest"},{"key":"253_CR69","doi-asserted-by":"publisher","unstructured":"Karag\u00f6 GE, Duarte AMS, Akoury E, Ippel H, Biernat J, Moran Luengo T, et al. Hsp90-tau complex reveals molecular basis for specificity in chaperone action. Cell. 2014 [cited 2016 Sep 2];156:963\u2013974. Available from: https:\/\/doi.org\/10.1016\/j.cell.2014.01.037 .","DOI":"10.1016\/j.cell.2014.01.037"},{"key":"253_CR70","doi-asserted-by":"crossref","unstructured":"Shimura H, Miura-Shimura Y, Kosik KS. Binding of tau to heat shock protein 27 leads to decreased concentration of Hyperphosphorylated tau and enhanced cell survival. J Biol Chem. 2004 [cited 2017 Jun 28];279:17957\u201317962. Available from: http:\/\/www.jbc.org\/content\/279\/17\/17957.full.pdf .","DOI":"10.1074\/jbc.M400351200"},{"key":"253_CR71","unstructured":"Huang C, Cheng H, Hao S, Zhou H, Zhang X, Gao J, et al. Heat Shock Protein 70 Inhibits \u03b1-Synuclein Fibril Formation via Interactions with Diverse Intermediates. [cited 2017 Jun 27]; Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0022283606011156?via%3Dihub ."},{"key":"253_CR72","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1126\/science.1067389","volume":"295","author":"PK Auluck","year":"2002","unstructured":"Auluck PK, Edwin Chan HY, Trojanowski JQ, Lee VM-Y, Bonini NM. Chaperone suppression of \u03b1-Synuclein toxicity in a Drosophila model for Parkinson\u2019s disease. Science (80-. ). 2002;295:865\u20138. Available from: http:\/\/www.sciencemag.org\/cgi\/doi\/10.1126\/science.1067389 .","journal-title":"Science (80-. )"},{"key":"253_CR73","doi-asserted-by":"crossref","unstructured":"Luk KC, Mills IP, Trojanowski JQ, Lee VMY. Interactions between Hsp70 and the hydrophobic Core of \u03b1-Synuclein inhibit fibril assembly. Biochemistry. 2008;47:12614\u201325. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2648307\/ .","DOI":"10.1021\/bi801475r"},{"key":"253_CR74","doi-asserted-by":"crossref","unstructured":"Ebrahimi-Fakhari D, Saidi L-J, Wahlster L. Molecular chaperones and protein folding as therapeutic targets in Parkinson\u2019s disease and other synucleinopathies. Acta Neuropathol Commun. 2013:1\u201379. Available from: http:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-1-79 .","DOI":"10.1186\/2051-5960-1-79"},{"key":"253_CR75","doi-asserted-by":"publisher","first-page":"23727","DOI":"10.1074\/jbc.M503326200","volume":"280","author":"Y Shin","year":"2005","unstructured":"Shin Y, Klucken J, Patterson C, Hyman BT, McLean PJ. The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates \u03b1-synuclein degradation decisions between proteasomal and lysosomal pathways. J Biol Chem. 2005;280:23727\u201334.","journal-title":"J Biol Chem"},{"key":"253_CR76","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1002\/prot.23152","volume":"79","author":"IB Bruinsma","year":"2011","unstructured":"Bruinsma IB, Bruggink KA, Kinast K, Versleijen AAM, Segers-Nolten IMJ, Subramaniam V, et al. Inhibition of \u03b1-synuclein aggregation by small heat shock proteins. Proteins Struct Funct Bioinf. 2011;79:2956\u201367.","journal-title":"Proteins Struct Funct Bioinf"},{"key":"253_CR77","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1016\/j.jmb.2013.08.006","volume":"425","author":"S Daturpalli","year":"2013","unstructured":"Daturpalli S, Waudby CA, Meehan S, Jackson SE. Hsp90 inhibits \u03b1-synuclein aggregation by interacting with soluble oligomers. J Mol Biol. 2013;425:4614\u201328. Elsevier B.V., Available from: https:\/\/doi.org\/10.1016\/j.jmb.2013.08.006 .","journal-title":"J Mol Biol"},{"key":"253_CR78","doi-asserted-by":"crossref","unstructured":"Falsone SF, Kungl AJ, Rek A, Cappai R, Zangger K. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein \u03b1-synuclein. J Biol Chem. 2009 [cited 2017 Jun 27];284:31190\u201331199. Available from: http:\/\/www.jbc.org\/content\/284\/45\/31190.full.pdf .","DOI":"10.1074\/jbc.M109.057240"},{"key":"253_CR79","doi-asserted-by":"crossref","unstructured":"Dhillon JKS, Riffe C, Moore BD, Ran Y, Chakrabarty P, Golde TE, et al. A novel panel of \u03b1-synuclein antibodies reveal distinctive staining profiles in synucleinopathies. PLoS One. 2017 [cited 2018 Apr 13];12. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC5599040\/ .","DOI":"10.1371\/journal.pone.0184731"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13024-018-0253-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-018-0253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T21:47:31Z","timestamp":1661291251000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-018-0253-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["253"],"URL":"https:\/\/doi.org\/10.1186\/s13024-018-0253-9","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]},"assertion":[{"value":"10 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animals used in the described experiments were maintained in accordance with standards and policies set by the University of Florida\u2019s Institutional Animal Care and Use Committee (IACUC) and the Environmental Health & Safety division.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}